ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,433,066 | +28.1% | 1,710,872 | +45.1% | 0.12% | -8.3% |
| Q2 2023 | $36,253,004 | +134.7% | 1,179,343 | +175.1% | 0.13% | +100.0% |
| Q1 2023 | $15,448,115 | -50.6% | 428,757 | -45.9% | 0.07% | -60.7% |
| Q4 2022 | $31,301,618 | +141.0% | 792,045 | +145.0% | 0.17% | +118.2% |
| Q3 2022 | $12,990,000 | +448.6% | 323,283 | +473.9% | 0.08% | +352.9% |
| Q2 2022 | $2,368,000 | -77.5% | 56,330 | -79.1% | 0.02% | -80.9% |
| Q1 2022 | $10,513,000 | +350.4% | 269,853 | +360.8% | 0.09% | +394.4% |
| Q4 2021 | $2,334,000 | -22.4% | 58,568 | -29.6% | 0.02% | -52.6% |
| Q3 2021 | $3,007,000 | -15.6% | 83,204 | -4.3% | 0.04% | -7.3% |
| Q2 2021 | $3,564,000 | +18.1% | 86,946 | +21.2% | 0.04% | -4.7% |
| Q3 2020 | $3,018,000 | – | 71,728 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |